Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Hezhi Pharmaceutical Group is a comprehensive pharmaceutical enterprise based in Tianjin, China, specializing in the research, development, production, and sale of Traditional Chinese Medicine (TCM), chemical drugs, and health supplements. The company operates multiple large-scale production facilities certified by GMP standards, offering a wide range of dosage forms including tablets, capsules, granules, and oral liquids. Hezhi Pharmaceutical is recognized as a high-tech enterprise that integrates traditional herbal wisdom with modern pharmaceutical manufacturing technologies. In addition to its own product portfolio, the group provides extensive contract manufacturing (CMO/CDMO) services for domestic and international partners. Its business reach extends across major therapeutic areas such as cardiovascular health, respiratory care, and digestive system disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Hezhi Pharmaceutical Group.